Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Paul Chaplin
Pharma
Bavarian Nordic's longtime CEO Paul Chaplin to depart
Chaplin, who became CEO in 2014, said in a statement Monday that he’s stepping down because his family wants to return to Australia.
Fraiser Kansteiner
Mar 2, 2026 10:23am
BN reopens facility, works to increase monkeypox vax production
Aug 24, 2022 11:42am
JPM execs speak on 2018: Pricing moves, yes. M&A frenzy, no
Jan 15, 2018 9:38am
After Prostvac flop, Bavarian Nordic showcases RSV data
Sep 25, 2017 2:10pm
Bavarian Nordic posts positive phase 2 for universal RSV shot
Jun 27, 2017 12:49pm
